Apr 21, 2021 14:29 Source: BSE
Ajanta Pharma - Board Meeting Intimation for Considering And Approving Results
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Friday, 30th April 2021 to inter-alia consider and approve: a. Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2021; and b. Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2021. You are requested to please take note of the same and disseminate to all concerned.